2nd SCI / RSC Symposium on Antimicrobial Drug Discovery

12 November 2018 12:00 - 13 November 2018 16:45, London , United Kingdom


Introduction
Monday 12 - Tuesday 13 November 2018, SCI, London, UK
Monday 12 November
  • 12:00 Registration, exhibition and lunch
  • 13:00 Opening remarks
  • 13:10 Antibiotics: challenges and opportunities - Dr Stephen Baker, GlaxoSmithKline
  • 13:55 Rational and irrational discovery of novel interventions to treat drug-resistant infections - Prof Matt Cooper, University of Queensland and Inflazome
  • 14:40 Flash poster presentations
  • 15:00 Refreshment break and exhibition
  • 15:30 Novel gold(I) complexes for the treatment of Gram-positive and Gram-negative bacterial infections - Dr Paul King, Auspherix
  • 16:00 Towards photopharmacological antimicrobial chemotherapy - Dr Matthew Fuchter, Imperial College London
  • 16:30 SPARKing new antibiotic discovery - Wes King, The Pew Charitable Trusts
  • 17:00 Research and development of new antimicrobial drugs and combinations: a not-for-profit approach - Prof Laura Piddock, Global Antibiotic Research & Development Partnership
  • 17:45 Networking and refreshments

Tuesday 13 November
  • 09:00 Rules for bacterial penetration - what we know and what we don't - Dr Paul Finn, Oxford Drug Design
  • 09:30 Reversing efflux-mediated resistance to reinvent broad-spectrum antibiotics  -Dr K Miraz Rahman, King’s College London
  • 10:00 Predictive guidelines for compound accumulation lead to new broad-spectrum antibiotics - Prof Paul Hergenrother, University of Illinois
  • 10:45 Refreshment break and exhibition
  • 11:15 Non-hydroxamate LpxC inhibitors - Dr Alastair Parkes, Evotec
  • 11:45 Novel immunotherapeutics to target Gram-negative bacterial infections - Dr Emma Leire, Centauri Therapeutics
  • 12:15 Analysis of poatassium (K+) efflux systems (Kef) as an antibiotic target n pathogenic bacteria - Catherine Haslam, University of Oxford
  • 12:30 Turning strength in to weakness: exploiting resistance as a novel therapeutic target - Lindsay Evans, Imperial College, London
  • 12.45 MAPS: Multiparameter Assay for Profiling Susceptibiity - Lisa Miller, University of York
  • 13:00 Lunch and exhibition
  • 14:00 Short antimicrobial peptides - their potential against multidrug-resistant bacteria - Dr Kai Hilpert, St George’s, University of London
  • 14:30 From HTS to preclinical candidate: a novel small-molecule antibiotic for the treatment of drug-resistant Neisseria gonorrhoeae - Dr Paul Meo, Summit Therapeutics
  • 15:00 Refreshment break and exhibition
  • 15:30 Metallo β-lactamase inhibitors: an approach to combat the threat of emerging carbapenem resistance due to metallo β-lactamase enzymes in Gram-negative bacteria - Dr David Davies, AntaBio
  • 16:00 Challenges in antibacterial drug discovery - Prof Ian Gilbert, University of Dundee
  • 16:45 Closing remarks
Call for Poster Abstracts
Anyone wishing to present a poster should submit a one-page abstract to conferences@soci.org by Fri 14 September 2018 with "AMR-poster abstract" in the subject line.  Selected poster presenters will be given the opportunity to give a flash presentation.
Bursaries
A limited number of bursaries are available to SCI/RSC student members to cover their registratation fees and contribute to their travel and accomodation costs.  To apply for a bursary, please send an email to conferences@soci.org by Fri 14 September 2018 with "AMR II - burrsary application" in the subject line.
Exhibition and Sponsorship
An exhiition will take place alongside the conference. Companies and related organisations who may wish to exhibit, please email conferences@soci.org for further information and prices.  Spaces are limited and will be allocated on a first-come first-served basis

#AntibioticGap
Speakers
Venue
SCI

SCI, 14/15 Belgrave Square, London , SW1X 8PS, United Kingdom

Organised by
Organising Committee
  • Dr Liam Cox, SCI / University of Birmingham
  • Dr Caroline Low, SCI / Comp[utational Medicinal Chemistry COnsultant
  • Dr Sarah Major, SCI / Evotec (UK) Ltd
  • Dr Pascal Savy, SCI / Charles River Laboratories
  • Dr Francis Wilson, RSC / Summit Therapeutics
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement Spotlight Advertisement

E-mail Enquiry
*
*
*
*